PERICARDIOCENTESIS VS SUBXYPHOID PERICARDIOTOMY - COMPARISON OF EFFICACY AND SAFETY

Małgorzata Dybowska,Paweł Kuca,Juliusz Gątarek,Janusz Burakowski,Franciszek Grzegorczyk,Witold Tomkowski,Renata Langfort,Monika Szturmowicz,Cezary Czajka,Piotr Rudziński ,Adam Jóźwik

doi:10.21474/ijar01/7684

Abstract

17Sep 2018 PERICARDIOCENTESIS VS SUBXYPHOID PERICARDIOTOMY - COMPARISON OF EFFICACY AND SAFETY Małgorzata Dybowska , Witold Tomkowski , Monika Szturmowicz , Paweł Kuca , Janusz Burakowski , Franciszek Grzegorczyk , Cezary Czajka , Juliusz Gątarek , Piotr Rudzinski , Adam Jozwik and Renata Langfort. Cardio-Pulmonary Intensive Care Department, National Institute of Tuberculosis and Lung Diseases, Warsaw/ Poland. I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw/ Poland. Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw/ Poland. Computer Science Department, Faculty of Physics and Applied Informatics, University of Ł?dź/ Poland. Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw/Poland.

Highlights

Safety of therapy was assessed by the number of complications like: arrhythmia, respiratory failure requiring respiratory treatment, clinically relevant bleeding, pneumothorax and myocardial injury
Background:-Comparison of safety and effectiveness of Received: 18 July 2018 Final Accepted: 24 August 2018 Published: September 2018 pericardiocentesis versus subxyphoid pericardiotomy in patients with large pericardial effusion (PE) defined as more than 2 cm fluids behind the posterior wall of left ventricle measured by echocardiography
Methods:-A retrospective analysis was performed on consecutive patients with the diagnosis of large PE hospitalized in the Institute of Tuberculosis and Lung Diseases in 2007- 2017

Summary

RESEARCH ARTICLE

PERICARDIOCENTESIS VS SUBXYPHOID PERICARDIOTOMY - COMPARISON OF EFFICACY AND SAFETY. 1. Cardio-Pulmonary Intensive Care Department, National Institute of Tuberculosis and Lung Diseases, Warsaw/. 2. I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw/ Poland. 3. Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw/ Poland. 4. Computer Science Department, Faculty of Physics and Applied Informatics, University of Łódź/ Poland. 5. Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw/Poland

Manuscript History

Findings

Paroxysmal AF